Supplementary Tables – Clinical effectiveness outcomes and healthcare resource utilization of patients diagnosed with small-cell lung cancer

Supplemental Table 1. Summary of Treatment Distribution for Patients with eSCLC by Regimen-based Line for 1L, 2L, and 3L Supplemental Table 2. Treatment Regimen Distribution for Patients with eSCLC by Regimen-Based Line of Treatment for 1L, 2L, and 3L Supplemental Table 3. Healthcare Resource Utilization by Performance Status for 1L Therapy Supplemental Table 4. Mixed Model for General Physical Symptoms Supplemental Table 5. Mixed Model for Treatment Side Effects Supplemental Table 6. Mixed Model for Acute Distress Supplemental Table 7. Mixed Model for Despair Supplemental Table 8. Mixed Model for Impaired Ambulation Supplemental Table 9. Mixed Model for Impaired Performance Supplemental Table 10. Demographic Characteristics, Clinical Characteristics, and Comorbidities of Patients with eSCLC by Systemic Treatment